Free beta — full access, free until October 2026. No card, no auto-charge — paid plans are opt-in when they launch.
Company
IntelGenx Technologies Corp. (0001098880)
Standardized SEC financial data for IntelGenx Technologies Corp. — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001098880 · Pharmaceutical Preparations.
Income statement
USD
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
Revenue
$1.8M
$742K
$1.5M
$1.5M
$950K
$1.0M
R&D expense
$5.1M
$3.8M
$2.6M
$2.7M
$3.0M
$3.3M
SG&A expense
$5.0M
$5.8M
$3.0M
$3.8M
$4.7M
$4.8M
Operating income
-$9.0M
-$9.6M
-$6.3M
-$8.0M
-$9.4M
-$9.5M
Interest expense
$1.1M
$1.2M
$1.2M
$1.5M
$1.3M
$1.6M
Pretax income
-$10.1M
-$10.7M
-$7.0M
-$9.3M
-$10.7M
-$9.9M
Income tax
$0
$0
$0
$0
$0
$0
Net income
-$10.1M
-$10.7M
-$7.0M
-$9.3M
-$10.7M
-$9.9M
EPS (diluted)
—
—
—
$-0.07
$-0.07
$-0.06
Standardized from IntelGenx Technologies Corp.'s SEC filings — per-share figures split-adjusted. Full history via the API.